Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: A longitudinal study

Schizophrenia Research

Volumn 48, Issue 1, 2001, Pages 17-28

  Cuesta, Manuel J ^a   Peralta, Victor ^a   Zarzuela, Amalia ^a  

^a Universidad Pública de Navarra   (Spain)

Author keywords

Antipsychotics; Cognitive function; Neuroleptics; Olanzapine; Schizophrenia

Indexed keywords

BIPERIDEN; CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; ZOTEPINE;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MALE; NEGATIVE SYNDROME; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; SCHIZOPHRENIA; SEX DIFFERENCE; SOCIAL STATUS; SYMPTOMATOLOGY; VERBAL BEHAVIOR; VERBAL MEMORY; VISUOMOTOR COORDINATION;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHRONIC DISEASE; COGNITION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; PIRENZEPINE; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SINGLE-BLIND METHOD;

EID: 0035280269     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(00)00112-2     Document Type: Article

References (50)

1. Neurocognitive impairment in schizophrenia and how it affects treatment options
2. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance
3. Effects on neuropsychological function in chronic schizophrenic patients
4. Evaluating the effects of antipsychotics on cognition in schizophrenia
5. Alteraciones cognitivas: Una realidad en el trastorno esquizofrénico
6. Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder. A pilot study
7. Comparative drugs and costs of antipsychotic medication
8. Clozapine and neuropsychology of schizophrenia
9. Pharmacologic strategies for augmenting cognitive performance in schizophrenia
10. The effect of clozapine on cognitive functioning in treatment resistant schizophrenic patients
11. Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenic patients treated with clozapine
12. Cognitive dysfunction in schizophrenia: Comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs
13. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia
14. Effects of neuroleptic medication on the cognition of patients with schizophrenia: A review of recent studies
15. Long-term impact of clozapine and psychosocial treatment on psychiatric symptoms and cognitive functioning
16. What are the functional consequences of neurocognitive deficits in schizophenia?
17. Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
18. Improvement in cognitive function and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine
19. Effects of psychiatric disorders and their somatic treatments on neuropsychological test results
20. The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome
21. The effect of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic patients
22. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis
23. Risperidone versus haloperidol on secondary memory: Can newer medications aid learning?
24. The effect of neuroleptics on cognitive and psychomotor function
25. Medication and cognitive functioning in schizophrenia
26. Effects on cognitive function in schizophrenia
27. Clinical and neurocognitive effects of clozapine and risperidone in treatment-refractory schizophreniz patients: A prospective study
28. The effects of clozapine on cognitive functioning in schizophrenia
29. The effect of neuroleptics on neuropsychological test results of schizophrenics
30. Dimensions of outcome with clozapine
31. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
32. Improvement of cognitive function in schizophrenic patients receiving clozapine or zotiepine: Results from a double-blind study
33. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET
34. Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy
35. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone and haloperidol
36. L'Examen psychologique
37. Risperidone, negative symptoms and cognitive deficit in schizophrenia: An open study
38. The cognitive efficacy of atypical antipsychotics in schizophrenia
39. Data analytic techniques for treatment outcomes studies with pretest/posttest measurements: An extensive primer
40. Relation of neuroleptic and anticholinergic medication to cognitive fuctions in schizophrenia
41. The effect of risperidone on cognition in patients with schizophrenia
42. Studies of interference in serial verbal reactions
43. The functional significance of symptomatology and cognitive function in schizophrenia
44. Standardized memory scale for clinical use
45. Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia